GYNECOLOGICAL MALIGNANCIES IN SOUTH PUNJAB REGION OF PAKISTAN – A DESCRIPTIVE STUDY
Main Article Content
Keywords
Gynecological Malignancies
Abstract
Background and Objectives: Gynecological malignancies, including cancers of the cervix, ovary, endometrium, and vulva, are significant contributors to morbidity and mortality among women worldwide. In Pakistan, particularly in the South Punjab region, there is a need for detailed epidemiological data to better understand the burden of these cancers and to guide public health interventions.
Material & Methods: This descriptive, cross-sectional study was conducted in the Department of Pathology, at Bahawal Victoria Hospital, Bahawalpur from January 2022 to December 2023. A total of 300 female patients diagnosed with gynecological malignancies were included. Data were collected on demographics, clinical presentations, tumor types, stages at diagnosis, and treatment modalities. Histopathological diagnoses were confirmed through biopsy. Descriptive statistics were used to summarize patient characteristics, and frequencies of various malignancies were calculated.
Results: The most common gynecological malignancy identified was cervical cancer, accounting for 40% of cases, followed by ovarian cancer (30%), endometrial cancer (20%), and vulvar cancer (10%). The majority of patients presented with advanced-stage disease (Stage III or IV), particularly for ovarian and cervical cancers. Treatment modalities varied, with surgery, chemotherapy, and radiotherapy being the most common approaches. Late-stage presentation and limited access to early screening were significant challenges observed in this population.
Conclusion: Cervical and ovarian cancers are the most prevalent gynecological malignancies in South Punjab, with a high proportion of cases diagnosed at advanced stages. These findings underscore the urgent need for enhanced screening programs, early detection initiatives, and public awareness campaigns to reduce the burden of gynecological cancers in this region. Improved access to healthcare facilities and timely treatment can significantly improve patient outcomes.
References
2. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5;
3. Crane K. Cancer in the developing world: Palliative care gains ground in developing countries. J Natl Cancer Inst. 2010 Nov 3;102(21):1613–5.
4. Sylla BS, Wild CP. A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer. 2012 Jan 15;130(2):245–50.
5. Jamal Shahid, Mamoon Nadira, Mushtaq Sajid, Luqman Muhammad, Moghal Saleha. The pattern of gynecological malignancies in 968 cases from Pakistan. Annals of Saudi Medicine [Internet]. 2006 Sep 1;26(5):382–4. Available from: https://doi.org/10.5144/0256-4947.2006.382
6. Rauf B, Hassan L, Ahmed S. Management of gestational trophoblastic tumours: a five-year clinical experience. J Coll Physicians Surg Pak. 2004 Sep;14(9):540–4.
7. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209–49.
8. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17–48.
9. Ør Knudsen A, Schledermann D, Nyvang GB, Mogensen O, Herrstedt J, Academy of Geriatric Cancer Research (AgeCare). Trends in gynecologic cancer among elderly women in Denmark, 1980-2012. Acta Oncol. 2016;55 Suppl 1:65–73.
10. Piechocki M, Koziołek W, Sroka D, Matrejek A, Miziołek P, Saiuk N, et al. Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980-2018). Clin Epidemiol. 2022;14:95–114.
11. Somasegar S, Bashi A, Lang SM, Liao CI, Johnson C, Darcy KM, et al. Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis. Obstet Gynecol. 2023 Oct 1;142(4):978–86.
12. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006;117:147–55; discussion 155-156.
13. Aziz Z, Sana S, Saeed S, Akram M. Institution based tumor registry from Punjab: five year data based analysis. J Pak Med Assoc. 2003 Aug;53(8):350–3.
14. Albalawi Y. Pattern of Ovarian and Uterine Malignancies in Tabuk City, Saudi Arabia: A Retrospective Study. Clinical Cancer Investigation Journal [Internet]. 2024;13(1–2024):9–12. Available from: https://ccij-online.org/article/pattern-of-ovarian-and-uterine-malignancies-in-tabuk-city-saudi-arabia-a-retrospective-study-dg0evh8vyrosbii
15. Manzoor H, Naheed H, Ahmad K, Iftikhar S, Asif M, Shuja J, et al. Pattern of gynaecological malignancies in south western region of Pakistan: An overview of 12 years. Biomed Rep [Internet]. 2017 Nov;7(5):487–91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663976/
16. Zhou WL, Yue YY. Trends in the Incidence of Vulvar and Vaginal Cancers With Different Histology by Race, Age, and Region in the United States (2001-2018). Int J Public Health. 2022;67:1605021.
17. Cooley JJP, Maguire FB, Morris CR, Parikh-Patel A, Abrahão R, Chen HA, et al. Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California. Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):91–7.
18. Priyadarshini L, Pradhan SK. Pattern of Renal Histopathological Findings in Children: A Single Center Study. JCDR [Internet]. 2019; Available from: https://jcdr.net /article_fulltext.asp?issn=0973-709x&year=2019&volume=13&issue=12&page=SC01&issn=0973-709x&id=13352
19. Khan A, Sultana K. Presenting signs and symptoms of ovarian cancer at a tertiary care hospital. J Pak Med Assoc. 2010 Apr;60(4):260–2.
20. Torpy JM, Burke AE, Golub RM. JAMA patient page. Ovarian cancer. JAMA. 2011 Jun 15;305(23):2484.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Azra Akhtar
Consultant Histopathology and Cytopathology, Buch International Hospital, Multan, Pakistan
Asmah Afzal
Assistant Professor, Department of Pathology, Quaid-e-Azam Medical College Bahawalpur, Pakistan
Firdous Iqbal
Assistant Professor, University of Health Sciences, Lahore, Pakistan
Fatima Khalid
Senior demonstrator, Department of Pathology, Al Aleem Medical college, Lahore, Pakistan
Saroash Iqbal
Assistant Professor, Al Aleem Medical College, Lahore, Pakistan
Uzma Shaheen
Associate Professor, Department of Pathology, D G khan Medical College, Dera Ghazi Khan, Pakistan